Medicine
Volume 37, Issue 7 , Pages 326-329, July 2009

HIV testing and monitoring

Anna Maria Geretti MD PhD FRCPath is Consultant and Honorary Senior Lecturer in Virology at the Royal Free Hampstead NHS Trust and UCL Medical School in London, UK. Competing interests: the author has received reimbursement of expenses incurred while attending a symposium, fees for speaking and consulting, and research funds from several pharmaceutical and diagnostic companies, including Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Monogram Biosciences, Pfizer, Roche, Tibotec, and Virco

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1357-3039(09)00097-8

doi:10.1016/j.mpmed.2009.03.009

Medicine
Volume 37, Issue 7 , Pages 326-329, July 2009

Article Tools

* Image Usage & Resolution